Thanks for sharing, I guess its a point of Conjecture when a...

Thanks for sharing, I guess its a point of Conjecture when a trial starts, some say once recruitment has began, while others say when treatment begins. I suspect as always there is a lot of work not immediately obvious to onlookers, first the potential patients need to be found, then they have to be evaluated against the criteria, and once cleared [or rejected] their baseline established. Once all that is done, they can start taking the medication. And I'm sure there are other things the uninitiated like myself cant foresee.

We are fortunate that Healy essentially become our CRO, part of the cost saving involved I assume, is because they are a non profit organization and not a commercial entity like other CRO's are. They also have a network of pre determined sites waiting to be involved. We are fortunate to be selected.

Wouldn't be a coup if we can start on other neurological diseases before the ALS trial is completed and run concurrently ? That's probably getting a little ambitious but who knows with a "partner" or funding through a "grant" its not impossible.

Looking forward to news on these issues.


Cheers